Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTENTION: Tenofovir Alafenamide in Chronic Hepatitis B Patients Beyond Treatment Indications
NCT03753074Phase 4Active, not recruiting
- Start
- Feb 2019
- Primary completion
- Dec 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir alafenamide in Chronic Hepatitis B (CHB). Started Feb 2019; status: active, not recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03753074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03753074.